Montelukast is indicated for the prophylaxis and chronic treatment of asthma in pediatric patients 12 months of age and older. It is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 2 years of age and older.
Adverse effects: pharyngitis, influenza, fever, sinusitis, nausea, diarrhea, dyspepsia, otitis, viral infection, and laryngitis
|